Macomics is pleased to announce that Dr Lopez-Yrigoyen will Chair sessions at 2021 Tumour myeloid Microenvironment Directed Therapeutics Summit. She has extensive experience in genetic engineering/programming of human induced pluripotent stem cell derived macrophages and her sessions will highlight the advances and challenges in therapeutically targeting tumour-resident myeloid populations. The conference will be held virtually on March 16 – 18, 2021.